Abstract
Objective
To assess the effect of metformin on gene and protein expression of insulin receptor (IR) and IGF-1 (IGF-1R) receptor in human endometrial stromal cells after stimulation with androgen and insulin.
Study design
Primary culture of endometrial stromal cells stimulated with estrogen, progesterone with or without androgen or insulin, and treated with metformin for 24 and 48 h, followed by RNA (qRT-PCR) and protein (Western blot) extraction and analysis.
Results
IR gene expression was increased after treatment with insulin (2.9-fold change, p = 0.027) and further after metformin treatment (4.7-fold change, p < 0.001), and in IGF-1R, the group treated with insulin (1.83-fold change) and metformin (1.78-fold change) showed more expression, than control group (p < 0.001). Similarly, IR protein expression was increased after addition of metformin and insulin (249,869 ± 15,878) in relation to the other groups (p < 0.001). Furthermore, cells treated with insulin (153,634 ± 29,123) and androgen plus insulin (162,854 ± 86,258) had a higher IR protein expression compared to control (104,654 ± 5,634) and androgen group (71,595 ± 3,439, (p = 0.045 and 0.021). In groups treated with insulin (127,711 ± 4,591) and androgen plus insulin (151,098 ± 5,194) the protein IGF-1R was increased compared to control (79,355 ± 3,470) and the androgen-only group (79,326 ± 3,114) (p < 0.001).
Conclusion
Metformin in combination with insulin increased IR protein and gene expressions, while it had no influence on the protein expression of IGF-1R in endometrial stromal cells.
Similar content being viewed by others
References
Goodarzi MO, Bryer-Ash M (2005) Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes Metab 7(6):654–665. doi:10.1111/j.1463-1326.2004.00448.x
Palomba S, Falbo A, Orio F Jr, Zullo F (2009) Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 92(5):1646–1658. doi:10.1016/j.fertnstert.2008.08.087
Migrant Health in Europe (2004) Abstracts of the International Conference on Differences in Health and in Health Care Provision. 23-25 June 2004, Rotterdam, The Netherlands. Ethn Health 9 Suppl 1: S3–S128
Eisenhardt S, Schwarzmann N, Henschel V, Germeyer A, von Wolff M, Hamann A, Strowitzki T (2006) Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 91(3):946–952. doi:10.1210/jc.2005-1994
Trivax B, Azziz R (2007) Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol 50(1):168–177. doi:10.1097/GRF.0b013e31802f351b
Baran S, Api M, Goksedef BP, Cetin A (2010) Comparison of metformin and clomiphene citrate therapy for induction of ovulation in the polycystic ovary syndrome. Arch Gynecol Obstet 282(4):439–443. doi:10.1007/s00404-010-1497-y
Legro RS, Castracane VD, Kauffman RP (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59(2):141–154. doi:10.1097/01.OGX.0000109523.25076.E2
Katsiki N, Hatzitolios AI (2010) Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update. Curr Opin Obstet Gynecol 22(6):466–476. doi:10.1097/GCO.0b013e32833e1264
Tosca L, Solnais P, Ferre P, Foufelle F, Dupont J (2006) Metformin-induced stimulation of adenosine 5′ monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biol Reprod 75(3):342–351. doi:10.1095/biolreprod.106.050831
Chou KH, von Eye CH, Capp E, Spritzer PM (2003) Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial. Horm Metab Res 35(2):86–91. doi:10.1055/s-2003-39056
Sonntag B, Gotte M, Wulfing P, Schuring AN, Kiesel L, Greb RR (2005) Metformin alters insulin signaling and viability of human granulosa cells. Fertil Steril 84(Suppl 2):1173–1179. doi:10.1016/j.fertnstert.2005.04.043
Lessey BA (2011) Assessment of endometrial receptivity. Fertil Steril 96(3):522–529. doi:10.1016/j.fertnstert.2011.07.1095
Singh M, Chaudhry P, Asselin E (2011) Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol 210(1):5–14. doi:10.1530/JOE-10-0461
Paria BC, Ma W, Tan J, Raja S, Das SK, Dey SK, Hogan BL (2001) Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci USA 98(3):1047–1052. doi:10.1073/pnas.98.3.1047
Yin X, Pavone ME, Lu Z, Wei J, Kim JJ (2012) Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis. J Clin Endocrinol Metab 97(1):E35–E43. doi:10.1210/jc.2011-1527
De Fea K, Roth RA (1997) Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem 272(50):31400–31406
Tseng L, Mazella J (2002) Endometrial cell specific gene activation during implantation and early pregnancy. Front Biosci 7:d1566–d1574
Cavagna M, Mantese JC (2003) Biomarkers of endometrial receptivity–a review. Placenta 24(Suppl B):S39–S47
Lin J, Li R, Zhou J (2003) The influence of insulin on secretion of IGF-I and IGFBP-I in cultures of human endometrial stromal cells. Chin Med J (Engl) 116(2):301–304
Nayak NR, Giudice LC (2003) Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 24(4):281–296
Germeyer A, Jauckus J, Zorn M, Toth B, Capp E, Strowitzki T (2011) Metformin modulates IL-8, IL-1beta, ICAM and IGFBP-1 expression in human endometrial stromal cells. Reprod Biomed Online 22(4):327–334. doi:10.1016/j.rbmo.2010.11.006
Capp E, Jauckus J, von Eye Corleta H, Toth B, Strowitzki T, Germeyer A (2011) Does metformin influence the insulin-, IGF I- and IGF II-receptor gene expression and Akt phosphorylation in human decidualized endometrial stromal cells? Eur J Obstet Gynecol Reprod Biol 158(2):248–253. doi:10.1016/j.ejogrb.2011.05.012
Irwin JC, Kirk D, King RJ, Quigley MM, Gwatkin RB (1989) Hormonal regulation of human endometrial stromal cells in culture: an in vitro model for decidualization. Fertil Steril 52(5):761–768
Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA (2002) Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66(2):297–304
Zhang L, Liao Q (2010) Effects of testosterone and metformin on glucose metabolism in endometrium. Fertil Steril 93(7):2295–2298. doi:10.1016/j.fertnstert.2009.01.096
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685
Twisk JW (2004) Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 19(8):769–776
Gluszak O, Stopinska-Gluszak U, Glinicki P, Kapuscinska R, Snochowska H, Zgliczynski W, Debski R (2012) Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN Endocrinol 2012:569862. doi:10.5402/2012/569862
Costello MF, Chapman M, Conway U (2006) A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 21(6):1387–1399. doi:10.1093/humrep/dei501
Mahamed RR, Maganhin CC, Simoes RS, de Jesus Simoes M, Baracat EC, Soares JM Jr (2011) Effects of metformin on the reproductive system of androgenized female rats. Fertil Steril 95(4):1507–1509. doi:10.1016/j.fertnstert.2010.07.1093
Wang CF, Zhang G, Zhao LJ, Li XP, Qi WJ, Wang JL, Wei LH (2013) Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A. Chin Med J (Engl) 126(8):1560–1566
Fuhrmeister IP, Branchini G, Pimentel AM, Ferreira GD, Capp E, Brum IS, Corleta HvE (2014) Human granulosa cells: insulin and IGF1 receptors and aromatase expression modulation by metformin. Gynecol Obstet Investig. doi:10.1159/000358829
Umene K, Banno K, Kisu I, Yanokura M, Nogami Y, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, Tominaga E, Susumu N, Aoki D (2013) New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review). Oncol Rep 29(3):855–860. doi:10.3892/or.2013.2221
Campagnoli C, Abba C, Ambroggio S, Brucato T, Pasanisi P (2013) Life-style and metformin for the prevention of endometrial pathology in postmenopausal women. Gynecol Endocrinol 29(2):119–124. doi:10.3109/09513590.2012.706671
Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL (2010) Metformin is a potent inhibitor of endometrial cancer cell proliferation–implications for a novel treatment strategy. Gynecol Oncol 116(1):92–98. doi:10.1016/j.ygyno.2009.09.024
Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16(6):1695–1700. doi:10.1158/1078-0432.CCR-09-1805
Brown KA, Samarajeewa NU, Simpson ER (2013) Endocrine-related cancers and the role of AMPK. Mol Cell Endocrinol 366(2):170–179. doi:10.1016/j.mce.2012.06.016
Xie Y, Wang YL, Yu L, Hu Q, Ji L, Zhang Y, Liao QP (2011) Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. J Steroid Biochem Mol Biol 126(3–5):113–120. doi:10.1016/j.jsbmb.2010.12.006
Ladson G, Dodson WC, Sweet SD, Archibong AE, Kunselman AR, Demers LM, Williams NI, Coney P, Legro RS (2011) The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril 95(3):1059–1066. doi:10.1016/j.fertnstert.2010.12.002
Revel A (2012) Defective endometrial receptivity. Fertil Steril 97(5):1028–1032. doi:10.1016/j.fertnstert.2012.03.039
Acknowledgments
This work had financial support from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, proc. 470636/2012-2), Programa de Pós-graduação em Ciências Biológicas—Fisiologia da UFRGS (PPGFISIO) and Fundo de Incentivo à Pesquisa e Eventos (FIPE) do Grupo de Pesquisa e Pós-Graduação (GPPG) do Hospital de Clínicas de Porto Alegre. Edison Capp, Ilma Simoni Brum da Silva, Gustavo Dias Ferreira and Tadeu Ludwig do Nascimento are scholarship recipients from CNPq. Amanda de Barros Machado is scholarship recipient from CAPES—Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Conflict of interest
The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferreira, G.D., Germeyer, A., de Barros Machado, A. et al. Are growth factor receptors modulated by metformin in human endometrial stromal cells after stimulation with androgen and insulin?. Arch Gynecol Obstet 290, 361–367 (2014). https://doi.org/10.1007/s00404-014-3197-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-014-3197-5